Annovis Bio Leads Neurodegenerative Drug Development, Engages Investors at ROTH Healthcare Conference
Discover how Annovis Bio tackles neurodegenerative diseases and orphan conditions, its conference insights, stock outlook, and commitment to innovative therapies.
3 minutes to read